2024 HAE International (HAEi) Regional Conference Americas
Mar 15 - Mar 17, 2024
- Title: Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: RAPIDe-3 Phase 3 Trial Design
Presenter: Anete Grumach, M.D., Ph.D.
Format: Poster Presentation
Date, time: Friday, March 15, 8:20 p.m. EDT
- Title: Efficacy and Safety of Bradykinin B2 Receptor Antagonism with Deucrictibant Immediate-Release Capsule for Treatment of Hereditary Angioedema Attacks: Results of RAPIDe-1 Phase 2 Trial
Presenter: Markus Magerl, M.D.
Format: Poster Presentation
Date, time: Friday, March 15, 8:20 p.m. EDT
- Title: Early-Onset Response to the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Patients with Hereditary Angioedema Attacks
Presenter: Marcus Maurer, M.D.
Format: Poster Presentation
Date, time: Friday, March 15, 8:20 p.m. EDT
- Title: Efficacy and Safety of Oral Deucrictibant, a Potent Bradykinin B2 Receptor Antagonist, in Prophylaxis of Hereditary Angioedema Attacks: Results of CHAPTER-1 Phase 2 Trial
Presenter: Marc A. Riedl, M.D., M.S.
Format: Oral Presentation
Date, time: Saturday, March 16, 10:30 a.m. EDT
- Title: Understanding Patient Reasons not to Treat All Hereditary Angioedema (HAE) Attacks and Characteristics of Untreated HAE Attacks: Results from a Real World Survey
Presenter: William Lumry, M.D.
Format: Oral Presentation
Date, time: Saturday, March 16, 12:15 p.m. EDT